Navigation Links
Innovative Brain Scanning for Alzheimer's Screening Unveiled

Clinical Trials with the Neuronetrix' COGNISION Headset to Begin This Month

at the University of Kentucky

LEXINGTON, Ky., Jan. 23 /PRNewswire/ -- Researchers at the University of Kentucky Sanders-Brown Center on Aging are launching an Alzheimer's screening clinical trial with Neuronetrix's innovative brain scanning system, called COGNISION(TM). The study will involve brainwave assessments using a technology called event-related potentials (ERP's). The study is expected to validate the performance of the COGNISION(TM) system and to demonstrate the system's applicability in a primary care setting. Up to 100 Alzheimer sufferers and controls will participate over the next 6-12 months.

During the study patients will wear a sophisticated electronic headset which will record brain activity in response to an auditory stimulus. The process is similar to hearing screening tests performed on newborn infants throughout the country. The data is then uploaded to an online database where a powerful pattern recognition engine will correlate the ERP tests with known brainwave patterns.

The COGNISION(TM) test is expected to be the first approved Alzheimer's disease screening test which directly evaluates a patient's cognitive performance. "We are not looking at a surrogate biomarker which may or may not correlate with Alzheimer's. Instead, we are directly measuring the cognitive deficits caused by the disease," says K.C. Fadem, co-founder of Neuronetrix.

It is generally believed that the drugs used to treat Alzheimer's, such as market leader Aricept(R) from Pfizer, are most effective early in the disease process. Because of this, a national focus has been placed on the importance of Alzheimer's screening to determine optimum treatment paths in the early stage of the disease. At least one organization of medical experts, the AD Screening Discussion Group, has advocated that Alzheimer's disease screenings become a routine part of the application for Medicare.

Alzheimer's disease affects about 5 million Americans with 500,000 new cases reported each year. This number is expected to grow to 16 million by 2050. The CDC recently reported that Alzheimer's disease moved up to 7th place from 8th place among the leading causes of death in 2004, passing influenza and pneumonia.

The Sanders-Brown Center at the University of Kentucky is one of only 32 Alzheimer's Centers of Excellence in the country. Neuronetrix is planning a follow on study to evaluate the COGNISION(TM) System on a commercial scale that will be performed at other Alzheimer's Centers of Excellence including the University of Pennsylvania and Indiana University.

For more information, go to

SOURCE Neuronetrix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
2. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
3. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
4. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
5. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
6. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
7. Video: New Research Discovers Independent Brain Networks Control Human Walking
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
10. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
11. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma Services ... investment of at least $15.8  Million to expand ... Wilmington, NC . The expansion will provide ... meet the growing demands of the pharmaceutical and ... site expansion will provide up to 40,000 square ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
(Date:11/25/2015)... 25, 2015 USP 800 applies to ... (e.g. pharmacists, pharmacy technicians, nurses, physicians, physician assistants, ... chapter also covers all entities which store, prepare, ... other healthcare institutions, patient treatment clinics, physicians, practice ... --> What is the purpose ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 25, 2015 , ... According to an article published November 10th ... widely heralded as a breakthrough for performing hernia repairs. The article explains that the ... is that it can greatly reduce the pain that a patient might otherwise experience ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug ... a new cutting edge recovery program that has been 50 years in the making. ... individuals with the purpose to free addicts from the symptoms and negative behaviors of ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, ... from Bronx, N.Y. “I thought there had to be a convenient and comfortable way ... , The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. ...
Breaking Medicine News(10 mins):